Anti-transthyretin Antibodies

  • Published: Mar 15, 2018
  • Earliest Priority: Jul 02 2016
  • Family: 4
  • Cited Works: 4
  • Cited by: 0
  • Cites: 3
  • Additional Info: Cited Works Full text
Abstract

The invention provides antibodies that specifically bind to transthyretin (TTR). The antibodies can be used for treating or effecting prophylaxis of diseases or disorders associated with TTR accumulation or accumulation of TTR deposits (e.g., TTR amyloidosis). The antibodies can also be used for diagnosing TTR amyloidosis and inhibiting or reducing aggregation of TTR, among other applications.


Claims

Information currently unavailable.

Download PDF
Document Preview
Document History
  • Publication: Mar 15, 2018
  • Application: Jun 30, 2017
    WO IB 2017053987 W
  • Priority: Jul 2, 2016
    US US 201615201416 A

Download Citation


Sign in to the Lens

Feedback